HRG214 data
An immunotherapy invented by a researcher at Louisiana State University Medical Center in Shreveport, and manufactured by Cervida, has reversed signs of HIV infection. A total of 35 patients have been treated, according to a report that was given at the meeting of the International Cytokine Society and International Society for Interferon and Cytokine Research in Geneva.
The agent consists of five engineered antibodies that target conserved regions on HIV (three in gp160, one in reverse transcriptase, and one in the nuclear capsid). It was used alone and with two additional treatments, IFN inducer (an immunostimulant composed of muramyl dipeptide repeats), and natural type I cytokines (interferons, interleukin-2, and colony stimulating factors in a sub-lingual tablet). ...